CD16 (Fcgr3), essential for antigen presentation and immune activation [51], is implicated in AD pathogenesis: CD16-deficient animal models exhibit attenuated skin inflammation and humoral responses [52], alongside suppressed Th2/Th1/Th17 immunity and reduced inflammatory cytokines [52]. The gene discussed is FCGR3A; the disease is Alzheimer disease.